换一批
换一批Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial. The SYMPHONY Investigators. Sibrafiban versus Aspirin to Yield Maximum Protection from Ischemic Heart Events Post-acute Coronary Syndromes.
主题词
投药, 口服(Administration, Oral);老年人(Aged);心绞痛, 不稳定型(Angina, Unstable);阿司匹林(Aspirin);双盲法(Double-Blind Method);女(雌)性(Female);人类(Humans);男(雄)性(Male);中年人(Middle Aged);比值比(Odds Ratio);肟类(Oximes);哌啶类(Piperidines);血小板聚集抑制剂(Platelet Aggregation Inhibitors);血小板糖蛋白GPⅡb-Ⅲa复合物(Platelet Glycoprotein GPIIb-IIIa Complex);复发(Recurrence)
PMID
10665552
发布时间
2017-11-16
- 浏览133
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
